Tulip BioMed, Inc. Release: Independent Research Shows Presence of Protein Residue on Reusable Plastic Surgery Instruments Following Cleaning and Autoclaving
5/29/2007 10:22:11 AM
SAN DIEGO, CA -- (MARKET WIRE) -- May 29, 2007 -- Tulip BioMed™, Inc. (PINKSHEETS: TPBD), a developer of biodesign instruments for living tissue management, including instruments for plastic, cosmetic, and orthopedic surgeries, today released a summary of the results of a research investigation conducted at the University of California San Diego (UCSD) Medical Center that examined the interior surface of Tulip BioMed's disposable cannulas with the interior surfaces of non-Tulip reusable cannulas used in surgical settings. The study indicated that residue remains in reusable closed-end cannulas that have been previously used in plastic surgery procedures, despite cleaning. The research project was conducted by a team of medical doctors and researchers in the Division of Plastic Surgery at UCSD. The project was commissioned and paid for by Tulip BioMed.
comments powered by